![](https://cdn.sanity.io/images/0vv8moc6/contagion/aaf73b27e05b4cc0141c0df1ab2504803791dc4f-400x400.jpg?fit=crop&auto=format)
Pemgarda Maintains Effectiveness Against Evolving SARS-CoV-2 Variants
Invivyd announced that new in vitro data confirms Pemgarda (pemivibart) continues to effectively neutralize the dominant SARS-CoV-2 variant XEC. This underscores the monoclonal antibody's ongoing effectiveness despite the virus’s evolving variants. The …